# Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer

> **NCT02394535** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 25 (actual)

## Conditions studied

- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma
- Stage II Pancreatic Cancer AJCC v6 and v7
- Stage IIA Pancreatic Cancer AJCC v6 and v7
- Stage IIB Pancreatic Cancer AJCC v6 and v7
- Stage III Pancreatic Cancer AJCC v6 and v7

## Interventions

- **DRUG:** Capecitabine
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Nab-paclitaxel
- **OTHER:** Questionnaire Administration
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT02394535
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-12
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394535, "Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02394535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*